Showing results (291-300 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|November 23, 2019
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytesYu-Li Chen, Han-Wei Lin, Chung-Liang Chien, et al.Journal for Immunotherapy of Cancer|November 23, 2019
Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literatureMarcela Carausu, Arnaud Beddok, Adriana Langer, et al.Journal for Immunotherapy of Cancer|December 13, 2019
Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancerXuyao Zhang, Yichen Wang, Jiajun Fan, et al.Journal for Immunotherapy of Cancer|December 13, 2019
Genetic instability as a driver for immune surveillanceGuim Aguadé-Gorgorió, Ricard SoléJournal for Immunotherapy of Cancer|December 19, 2019
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitisHamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, et al.Journal for Immunotherapy of Cancer|February 27, 2020
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiencyFeng Li, Yuqiao Sheng, Weizhou Hou, et al.Journal for Immunotherapy of Cancer|February 27, 2020
On the mechanism of anti-CD39 immune checkpoint therapyDavid Allard, Bertrand Allard, John StaggJournal for Immunotherapy of Cancer|March 2, 2020
T-cell lymphoma secondary to checkpoint inhibitor therapyKartik Anand, Joe Ensor, Sai Ravi Pingali, et al.Journal for Immunotherapy of Cancer|March 2, 2020
Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinomaGemlyn George, Laura Schmidt, Parag Tolat, et al.Journal for Immunotherapy of Cancer|March 20, 2020
Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancerTakahide Toyoda, Toshiko Kamata, Kazuhisa Tanaka, et al.Pageof 424